價(jià)格 | ¥565 | ¥1520 | ¥2260 |
包裝 | 1mg | 5mg | 10mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-12 |
中文名稱:化合物 MK0752 | 英文名稱:MK-0752 |
CAS:471905-41-6 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.55% | 產(chǎn)品類別: 抑制劑 |
貨號(hào): T2625 |
名稱 | MK-0752 |
描述 | MK-0752, a γ-secretase inhibitor, reduces Aβ40 production(IC50=5 nM). |
激酶實(shí)驗(yàn) | Protein kinase assays : Protein kinase assays are either done in-house by ELISA-based assay methods (Kit, KDR, PDGFRα, and PDGFRβ) or by a radiometric method. In-house ELISA assays used poly(Glu:Tyr) as the substrate bound to the surface of 96-well assay plates; phosphorylation is then detected using an antiphosphotyrosine antibody conjugated to HRP. The bound antibody is then quantitated using ABTS as the peroxidase substrate by measuring the absorbance at 405/490 nm. All assays uses purified recombinant kinase catalytic domains that are either expressed in insect cells or in bacteria. The Kit and EGFR protein used for in-house assays are prepared internally; other enzymes are obtained. Recombinant Kit protein is expressed as an NH2-terminal glutathione S-transferase fusion protein in insect cells and is initially purified as a nonphosphorylated (nonactivated) enzyme with a relatively high Km for ATP (400 μM). In some assays, an activated (tyrosine phosphorylated) form of the enzyme is prepared by incubation with 1 mM ATP for 1 hour at 30 °C. The phosphorylated protein is then passed through a desalting column to remove the majority of the ATP and stored at ?80 °C in buffer containing 50% glycerol. The resultant preparation has a considerably higher specific activity and a lower Km for ATP (25 μM) than the initial nonphosphorylated preparation. The inhibition of Kit autophosphorylation by OSI-930 is assayed by incubation of the nonphosphorylated enzyme at 30 °C in the presence of 200 μM ATP and various concentrations of OSI-930. The reaction is stopped by removal of aliquots into SDS-PAGE sample buffer followed by heating to 100 °C for 5 minutes. The degree of phosphorylation of Kit is then determined by immunoblotting for both total Kit and phosphorylated Kit. |
體外活性 | 在豚鼠體內(nèi),口服 MK-0752(10 -30 mg/kg),在血漿,大腦和腦脊液中Aβ40以劑量依賴性減少.在獼猴中, MK-0752(240 mg/kg)能夠減少大腦中Aβ生成的生成. |
體內(nèi)活性 | 在人SH-SY5Y細(xì)胞中(IC50=5 nM),MK-0752能夠以劑量依賴性減少Aβ40。 |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | H2O : < 1 mg/mL (insoluble or slightly soluble) DMSO : 89 mg/mL (200.94 mM) Ethanol : 45 mg/mL (101.6 mM) |
關(guān)鍵字 | Aβ40 | inhibit | barrier | γ-secretase | blood-brain | Inhibitor | MK 0752 | CNS | MK0752 | MK-0752 | Gamma secretase |
相關(guān)產(chǎn)品 | Rutin | Valproic acid sodium salt | Tangeretin | Methyl tridecanoate | Valproic Acid | Notoginsenoside R1 | Carvacrol | Tramiprosate | Deferoxamine Mesylate | Anle138b | Dihydroergocristine mesylate | Ginsenoside Re |
相關(guān)庫(kù) | 抑制劑庫(kù) | 經(jīng)典已知活性庫(kù) | 抗癌活性化合物庫(kù) | 已知活性化合物庫(kù) | 神經(jīng)退行性疾病化合物庫(kù) | 口服活性化合物庫(kù) | 藥物功能重定位化合物庫(kù) | 抗癌臨床化合物庫(kù) | 抗癌藥物庫(kù) | 細(xì)胞重編程化合物庫(kù) |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.265100萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
¥2059.90 |
VIP13年
|
上海阿拉丁生化科技股份有限公司
|
2025-01-20 | |
¥1699.90 |
VIP2年
|
上海阿拉丁生化科技股份有限公司
|
2024-11-29 | |
詢價(jià) |
南京百鑫德諾生物科技有限公司
|
2024-09-26 | ||
詢價(jià) |
上海昶衍化工科技有限公司
|
2023-06-05 | ||
¥5000 |
石家莊三信凱發(fā)國(guó)際貿(mào)易有限公司
|
2023-06-05 |